Pharmaceutical products

Tender description

This Framework Agreement is for the supply of Intravenous Immunoglobulin (IVIgG) and Subcutaneous Immunoglobulin (IgG). The Goods have been split into four (4) categories, each of which is identified as a ‘Lot’. The Lots are as follows: Lot 1 — Human Normal Intravenous Immunoglobulin 5 % Lot 2 — Human Normal Intravenous Immunoglobulin 10 % Lot 3 — Human Normal Intravenous Immunoglobulin for Subcutaneous Use Lot 4 — Subcutaneous Immunoglobulin with Hyaluronidase All deliveries under the framework agreement will be to one central location, namely ‘The Scottish National Blood Transfusion Service’ (SNBTS), Edinburgh. Supply of Human Normal Intravenous Immunoglobulin 5 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot. Supply of Human Normal Intravenous Immunoglobulin 10 %, across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot. Supply of Human Normal Intravenous Immunoglobulin for subcutaneous use across various vial sizes including current Primary Immune Deficiencies (PID) usage. This lot will be awarded as a Ranked Multi Supplier Framework. It is envisaged that a maximum of six (6) suppliers will be awarded to this lot. Supply of Subcutaneous Immunoglobulin with Hyaluronidase. The Authority intends awarding all presentations within this Lot to a single supplier.